Leymus Genomics ApS

Leymus Genomics ApS (CVR number: 38106872) is a company from HERLEV. The company recorded a gross profit of -1341.5 kDKK in 2023. The operating profit was -1651.9 kDKK, while net earnings were -1269 kDKK. The profitability of the company measured by Return on Assets (ROA) was -145.7 %, which can be considered poor and Return on Equity (ROE) was -128.7 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -13.1 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. Leymus Genomics ApS's liquidity measured by quick ratio was 0.9 which is at a modest level. Thus, the company's liquid assets are in relative balance with its short-term liabilities, indicating a moderate liquidity position. While it's likely to meet its current obligations, financial flexibility may be constrained, and unexpected costs could pose challenges.